Potential application of p53 as an intermediate biomarker in Barrett's esophagus
- 1 March 1994
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 57 (3), 598-603
- https://doi.org/10.1016/0003-4975(94)90551-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohortGastroenterology, 1992
- The p53 tumour suppressor geneNature, 1991
- High-grade dysplasia in the columnar-lined esophagusThe American Journal of Surgery, 1991
- Surgical Therapy in Barrettʼs EsophagusAnnals of Surgery, 1990
- Barrett's Esophagus; Development of Dysplasia and AdenocarcinomaGastroenterology, 1989
- Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagusBritish Journal of Surgery, 1988
- Observer variation in the diagnosis of dysplasia in Barrett's esophagusHuman Pathology, 1988
- The spectrum of carcinoma arising in Barrettʼs esophagusThe American Journal of Surgical Pathology, 1984
- Columnar-lined lower esophagus: An acquired lesion with malignant predispositionThe Journal of Thoracic and Cardiovascular Surgery, 1975
- Adenocarcinoma of the Oesophagus and Ectopic Gastric MucosaBritish Journal of Cancer, 1952